Skip To Main Content
Pouria Akbarikoli on Muck Rack

Pouria Akbarikoli

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pouria

Contact Pouria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Minimal clinically important difference for cognitive scales in people with Parkinson’s disease with cognitive impairment

|
By Ghorban Taghizadeh, Negin Eissazade, Javier Pagonabarraga, Saül Martínez-Horta, Jaime Kulisevsky, Seyede Zohreh Jazaeri, Maryam Mehdizadeh, Azar Sharabiani, Pouria Akbarikoli
| Nature Verified
Abstract Cognitive impairment (CI) is a significant non-motor symptom of Parkinson’s disease (PD), necessitating effective assessment tools to evaluate treatment efficacy. Minimal Clinically Important Difference (MCID) thresholds provide critical benchmarks for interpreting cognitive intervention outcomes. This study establishes MCID values for PD Cognitive Rating Scale (PD-CRS), Scales for Outcomes in PD-Cognition (SCOPA-COG), and Montreal Cognitive Assessment (MoCA) in PD-CI.
Open in Who Shared Issue with article?
See all 1 articles